Melissa Paoloni is the Senior Vice President of Corporate and Strategic Development, joining OncoNano in December 2023. She heads our business development, alliance management, and corporate strategic planning efforts as we continue to advance our assets further into the clinic. Melissa brings 20 years of expertise in strategic partnering and collaborations across a variety of organizations including biopharma, diagnostics, public-private partnerships, and academia. Her most recent role was as Vice President of Corporate Development and External Alliances at Arcus Biosciences, where she led partnering efforts across the portfolio. Previously, she provided strategic organizational consulting to several large pharmaceutical companies across a variety of therapeutic areas, ran large scale research programs at University of California at San Francisco and the National Cancer Institute, and developed multiple consortia to support innovative drug development efforts. Her deep oncology experience guides our asset management activities, process improvements across the organization, and provides operational leadership to our growing team.
Dr. Paoloni received her Bachelors from Stanford University, her Doctorate in veterinary medicine from Tufts University, and completed her Masters in clinical research training at Duke University.